Published in PLoS One on July 18, 2016
Following the Preclinical Data: Leveraging the Abscopal Effect More Efficaciously. Front Oncol (2017) 0.75
Intercellular Communication of Tumor Cells and Immune Cells after Exposure to Different Ionizing Radiation Qualities. Front Immunol (2017) 0.75
Hypofractionated Irradiation Has Immune Stimulatory Potential and Induces a Timely Restricted Infiltration of Immune Cells in Colon Cancer Tumors. Front Immunol (2017) 0.75
Emerging Therapies for Stage III Non-Small Cell Lung Cancer: Stereotactic Body Radiation Therapy and Immunotherapy. Front Oncol (2017) 0.75
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci U S A (1993) 11.95
Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res (1992) 9.02
Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med (2012) 8.46
Biological activities of immunoglobulins of different classes and subclasses. Adv Immunol (1974) 5.22
Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clin Cancer Res (2009) 4.58
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Radiat Oncol Biol Phys (2004) 4.29
Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial. Lancet Oncol (2015) 3.57
Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst (2013) 3.07
Systemic effects of local radiotherapy. Lancet Oncol (2009) 2.97
Whole body irradiation; radiobiology or medicine? Br J Radiol (1953) 2.80
Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes. Proc Natl Acad Sci U S A (2010) 2.77
An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer. Cancer Immunol Res (2013) 2.30
The abscopal effect associated with a systemic anti-melanoma immune response. Int J Radiat Oncol Biol Phys (2012) 2.29
IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells. Proc Natl Acad Sci U S A (1982) 2.15
Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis. Gut (1998) 2.11
Immunogenic cancer cell death: a key-lock paradigm. Curr Opin Immunol (2008) 1.89
Th1 and Th2 CD4+ T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo. J Immunol (2000) 1.80
Radiation as an immunological adjuvant: current evidence on dose and fractionation. Front Oncol (2012) 1.76
Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma. Acta Oncol (2006) 1.74
Evolving synergistic combinations of targeted immunotherapies to combat cancer. Nat Rev Cancer (2015) 1.66
Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer. Cancer Res (1999) 1.60
Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy. Oncoimmunology (2014) 1.39
New paradigms and future challenges in radiation oncology: an update of biological targets and technology. Sci Transl Med (2013) 1.35
Flt3 ligand induces tumor regression and antitumor immune responses in vivo. Nat Med (1997) 1.35
The controversial abscopal effect. Cancer Treat Rev (2005) 1.34
Abscopal effects of radiation therapy: a clinical review for the radiobiologist. Cancer Lett (2013) 1.24
TLR agonists: our best frenemy in cancer immunotherapy. J Leukoc Biol (2013) 1.18
The role of complement in tumor growth. Adv Exp Med Biol (2014) 1.11
Abscopal effect of radiation on lung metastases of hepatocellular carcinoma: a case report. J Med Case Rep (2011) 1.02
Combinations of immunotherapy and radiation in cancer therapy. Front Oncol (2014) 1.01
Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors. Cancer Immunol Immunother (2015) 0.99
Case records of the Massachusetts General Hospital. Case 21-2013. A 68-year-old man with metastatic melanoma. N Engl J Med (2013) 0.97
Abscopal effect in a patient with chronic lymphocytic leukemia during radiation therapy: a case report. Cases J (2009) 0.96
Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation. Cell Death Dis (2013) 0.93
Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications. Front Immunol (2015) 0.92
The perspective of immunotherapy: new molecules and new mechanisms of action in immune modulation. Curr Opin Oncol (2014) 0.91
Radiotherapy and immunogenic cell death. Semin Radiat Oncol (2015) 0.89
Immuno-regulatory antibodies for the treatment of cancer. Expert Opin Biol Ther (2015) 0.89
Spontaneous regression of metastatic melanoma - clinical evidence of the abscopal effect. Eur J Surg Oncol (2013) 0.88
Therapeutic use of anti-CTLA-4 antibodies. Int Immunol (2014) 0.88
Clinical Development of Immune Checkpoint Inhibitors. Biomed Res Int (2015) 0.82
A structured light-based system for scanning subcutaneous tumors in laboratory animals. Comp Med (2008) 0.82
Systematic review of case reports on the abscopal effect. Curr Probl Cancer (2015) 0.80